| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 317.08 | 88 |
| GSM780708 | Untreated after 4 days (C2_1) | 384.488 | 90 |
| GSM780709 | Untreated after 4 days (C3_1) | 400.135 | 90 |
| GSM780719 | Untreated after 4 days (C1_2) | 335.251 | 88 |
| GSM780720 | Untreated after 4 days (C2_2) | 357.086 | 89 |
| GSM780721 | Untreated after 4 days (C3_2) | 409.227 | 90 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 415.699 | 90 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 351.799 | 89 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 347.327 | 89 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 402.102 | 90 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 372.028 | 89 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 349.874 | 89 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 332.87 | 88 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 351.17 | 89 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 309.767 | 88 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 341.183 | 89 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 347.413 | 89 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 365.258 | 89 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 383.813 | 89 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 347.772 | 89 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 369.023 | 89 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 364.155 | 89 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 376.602 | 89 |